Is Recommending 0.01% Atropine for Myopia Control Clinically Meaningful?-Reply
JAMA Ophthalmol
.
2024 Mar 1;142(3):272.
doi: 10.1001/jamaophthalmol.2023.6775.
Authors
Karla Zadnik
1
,
Ian Flitcroft
2
,
Houman D Hemmati
3
Affiliations
1
The Ohio State University College of Optometry, Columbus.
2
Centre for Eye Research, Dublin, Ireland.
3
Vyluma Inc, Bridgewater, New Jersey.
PMID:
38358778
DOI:
10.1001/jamaophthalmol.2023.6775
No abstract available
MeSH terms
Atropine*
Disease Progression
Humans
Mydriatics
Myopia* / drug therapy
Ophthalmic Solutions
Refraction, Ocular
Substances
Atropine
Mydriatics
Ophthalmic Solutions